RVNC

Revance Therapeutics, Inc.

Delisted

RVNC was delisted on the 5th of February, 2025.

80 hedge funds and large institutions have $301M invested in Revance Therapeutics, Inc. in 2014 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 40 increasing their positions, 19 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$20.1M
2 +$5.2M
3 +$2.95M
4
AllianceBernstein
AllianceBernstein
Tennessee
+$2.74M
5
JP Morgan Chase
JP Morgan Chase
New York
+$2.23M

Top Sellers

1 -$21.4M
2 -$15.9M
3 -$12.3M
4
DM
Deerfield Management
New York
-$8.72M
5
Zurich Cantonal Bank
Zurich Cantonal Bank
Switzerland
-$4.42M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$1.63M
27
$1.62M
28
$1.6M
29
$1.55M
30
$1.44M
31
$1.41M
32
$1.4M
33
$1.26M
34
$1.22M
35
$1.11M
36
$1.08M
37
$1.08M
38
$925K
39
$831K
40
$813K
41
$697K
42
$626K
43
$558K
44
$533K
45
$509K
46
$503K
47
$429K
48
$373K
49
$370K
50
$357K